Knuth A - Search Results

1

HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.

Huarte E, Karbach J, Gnjatic S, Bender A, Jäger D, Arand M, Atanackovic D, Skipper J, Ritter G, Chen YT, Old LJ, Knuth A, Jäger E. Huarte E, et al. Among authors: knuth a. Cancer Immun. 2004 Dec 16;4:15. Cancer Immun. 2004. PMID: 15600300 Free article.

2

Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.

Mischo A, Wadle A, Wätzig K, Jäger D, Stockert E, Santiago D, Ritter G, Regitz E, Jäger E, Knuth A, Old L, Pfreundschuh M, Renner C. Mischo A, et al. Among authors: knuth a. Cancer Immun. 2003 Jun 27;3:5. Cancer Immun. 2003. PMID: 12828452

3

Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.

Jäger D, Unkelbach M, Frei C, Bert F, Scanlan MJ, Jäger E, Old LJ, Chen YT, Knuth A. Jäger D, et al. Among authors: knuth a. Cancer Immun. 2002 Jun 28;2:5. Cancer Immun. 2002. PMID: 12747750

4

Urine antibody against human cancer antigen NY-ESO-1.

Jäger D, Stockert E, Karbach J, Herrlinger K, Atmaca A, Arand M, Chen YT, Gnjatic S, Old LJ, Knuth A, Jäger E. Jäger D, et al. Among authors: knuth a. Cancer Immun. 2002 Aug 6;2:10. Cancer Immun. 2002. PMID: 12747755 Free article.

5

Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.

Jäger E, Karbach J, Gnjatic S, Jäger D, Maeurer M, Atmaca A, Arand M, Skipper J, Stockert E, Chen YT, Old LJ, Knuth A. Jäger E, et al. Among authors: knuth a. Cancer Immun. 2002 Sep 19;2:12. Cancer Immun. 2002. PMID: 12747757 Free article.

6

Antigen-specific immunotherapy and cancer vaccines.

Jäger E, Jäger D, Knuth A. Jäger E, et al. Among authors: knuth a. Int J Cancer. 2003 Oct 10;106(6):817-20. doi: 10.1002/ijc.11292. Int J Cancer. 2003. PMID: 12918057 Free article. Review.

7

Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.

Al-Batran SE, Rafiyan MR, Atmaca A, Neumann A, Karbach J, Bender A, Weidmann E, Altmannsberger HM, Knuth A, Jäger E. Al-Batran SE, et al. Among authors: knuth a. Cancer Res. 2005 May 1;65(9):3937-41. doi: 10.1158/0008-5472.CAN-04-4621. Cancer Res. 2005. PMID: 15867394

8

Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.

Karbach J, Pauligk C, Bender A, Gnjatic S, Franzmann K, Wahle C, Jäger D, Knuth A, Old LJ, Jäger E. Karbach J, et al. Among authors: knuth a. Int J Cancer. 2006 Feb 1;118(3):668-74. doi: 10.1002/ijc.21391. Int J Cancer. 2006. PMID: 16152624 Free article.

9

Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.

Jäger D, Karbach J, Pauligk C, Seil I, Frei C, Chen YT, Old LJ, Knuth A, Jäger E. Jäger D, et al. Among authors: knuth a. Cancer Immun. 2005 Dec 12;5:11. Cancer Immun. 2005. PMID: 16335914

10

NY-ESO-1: review of an immunogenic tumor antigen.

Gnjatic S, Nishikawa H, Jungbluth AA, Güre AO, Ritter G, Jäger E, Knuth A, Chen YT, Old LJ. Gnjatic S, et al. Among authors: knuth a. Adv Cancer Res. 2006;95:1-30. doi: 10.1016/S0065-230X(06)95001-5. Adv Cancer Res. 2006. PMID: 16860654 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page